Neuroscience of addiction: relevance to prevention and treatment

ND Volkow, M Boyle - American Journal of Psychiatry, 2018 - Am Psychiatric Assoc
Addiction, the most severe form of substance use disorder, is a chronic brain disorder
molded by strong biosocial factors that has devastating consequences to individuals and to …

Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions

M Gaba, C Mohan - Medicinal Chemistry Research, 2016 - Springer
Imidazole and benzimidazole rings are the most important nitrogen-containing heterocycles,
which are widely explored and utilized by the pharmaceutical industry for drug discovery …

Alpha2‐adrenergic agonists for the management of opioid withdrawal

L Gowing, M Farrell, R Ali… - Cochrane Database of …, 2016 - cochranelibrary.com
Background Withdrawal is a necessary step prior to drug‐free treatment or as the endpoint
of long‐term substitution treatment. Objectives To assess the effectiveness of interventions …

Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives

G Martinotti, R Santacroce, M Pettorruso, C Montemitro… - Brain sciences, 2018 - mdpi.com
Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly
understood condition linked to hallucinogenic drugs consumption. The prevalence of this …

Anticraving medications for relapse prevention: a possible new class of psychoactive medications

CP O'Brien - American Journal of Psychiatry, 2005 - Am Psychiatric Assoc
Psychiatrists have gradually developed a list of medications that are effective in the
treatment of addictive disorders. Although alcoholism has received the most attention …

Opioid dependence treatment: options in pharmacotherapy

AL Stotts, CL Dodrill, TR Kosten - Expert opinion on …, 2009 - Taylor & Francis
The development of effective treatments for opioid dependence is of great importance given
the devastating consequences of the disease. Pharmacotherapies for opioid addiction …

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

JL Scavone, RC Sterling, EJ Van Bockstaele - Neuroscience, 2013 - Elsevier
Withdrawal from opiates, such as heroin or oral narcotics, is characterized by a host of
aversive physical and emotional symptoms. High rates of relapse and limited treatment …

Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.

SM Hyman, H Fox, KIA Hong, C Doebrick… - Experimental and …, 2007 - psycnet.apa.org
Background: Naltrexone is a nonaddictive medication that blocks the euphoric effects of
opioids. However, naltrexone treatment is associated with high rates of noncompliance and …

Opioid antagonists with minimal sedation for opioid withdrawal

L Gowing, R Ali, JM White - Cochrane Database of Systematic …, 2017 - cochranelibrary.com
Background Managed withdrawal is a necessary step prior to drug‐free treatment or as the
endpoint of long‐term substitution treatment. Objectives To assess the effects of opioid …

Evidence-based treatments of addiction

CP O'Brien - … Transactions of the Royal Society B …, 2008 - royalsocietypublishing.org
Both pharmacotherapy and behavioural treatment are required to relieve the symptoms of
addictive disorders. This paper reviews the evidence for the benefits of pharmacotherapy …